As I understand it, the Medicines Working Group is a meeting between delegates of the Australian and US governments to discuss those matters. The question that comes from the minister’s concern about the obvious price win for the big companies as against the UK, which you were just talking about, is: will this new system deliver lower prices for new drugs and what assurance do we have that it will? You are arguing that this legislation is required to do that, but can you tell us how it will achieve that and can you give us an assurance that that will be the case?